Failure of zinc gluconate in treatment of acute upper respiratory tract infections
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Zinc is a trace metal with in vitro activity against rhinovirus, the major etiologic agent in acute upper respiratory tract infections (URIs). A previous trial of zinc gluconate supported its efficacy in treating URIs, but the effectiveness of blinding was uncertain. We conducted a prospective randomized trial of zinc gluconate versus a taste-matched placebo of sucrose octaacetate. Lozenges containing either 23 mg of elemental zinc or placebo were taken every 2 h. Eleven URI symptoms were rated daily on a scale of 0 (not present) to 3 (severe). Duration of illness, reflected in the proportion of subjects remaining symptomatic on each day, was not significantly reduced (maximum difference of 12.6% on day 7, P = 0.09; 95% confidence interval, -6 to 31%) by either treatment. Severity of illness, assessed by using a summed severity score, was reduced incrementally by 7 to 8% on days 5 to 7 (P = 0.02) in subjects taking zinc. Adverse effects, mostly nausea and altered taste, were reported by 50% of subjects taking zinc. We conclude that while zinc gluconate may produce a small reduction in overall severity of symptoms, this is not clinically significant. Given the additional high incidence of adverse effects, zinc gluconate cannot be recommended for use in the treatment of acute URIs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study
Eby, G. A., Davis, D. R., & Halcomb, W. W. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.25.1.20 · Cited by 217
Effects of ascorbic acid on the common cold
Chalmers, T. C. (1975) · The American Journal of Medicine · doi:10.1016/0002-9343(75)90127-8 · Cited by 155
Cited by
Markers to measure immunomodulation in human nutrition intervention studies
Albers, R., Antoine, J.-M., Bourdet-Sicard, R., Calder, P. C., Gleeson, M., Lesourd, B., Samartín, S., Sanderson, I. R., Van Loo, J., Vas Dias, F. W., et al. (2005) · British Journal of Nutrition · doi:10.1079/bjn20051469 · Cited by 286
Singh, M., & Das, R. R. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001364.pub4 · Cited by 237
RetractedPrasad, A. S., Fitzgerald, J. T., Bao, B., Beck, F. W. J., & Chandrasekar, P. H. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-4-200008150-00006 · Cited by 228
Science, M., Johnstone, J., Roth, D. E., Guyatt, G., & Loeb, M. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.111990 · Cited by 157
Prasad, A. S., Beck, F. W. J., Bao, B., Snell, D., & Fitzgerald, J. T. (2008) · The Journal of Infectious Diseases · doi:10.1086/528803 · Cited by 121
Metadata
- Authors
- Smith, D. S., Helzner, E. C., Nuttall, C. E., Collins, M., Rofman, B. A., Ginsberg, D., Goswick, C. B., & Magner, A.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1989-05
- Volume
- 33
- Issue
- 5
- Pages
- 646-648
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2083340644
- Cited by
- 73
- References
- 2
- FWCI
- 2.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Failure of zinc gluconate in treatment of acute upper respiratory tract infections. https://app.cochat.ai/papers/10.1128/aac.33.5.646
- The paper
- Smith, D. S., Helzner, E. C., Nuttall, C. E., Collins, M., Rofman, B. A., Ginsberg, D., Goswick, C. B., & Magner, A. (1989). Failure of zinc gluconate in treatment of acute upper respiratory tract infections. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.33.5.646
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.